Systems And Methods To Detect Rare Mutations And Copy Number Variation - EP3591073

EP3591073

GUARDANT HEALTH
Application Number
EP19192885A
Filing Date
Sep 4, 2013
Status
Granted And Under Opposition
Oct 29, 2021
Grant Date
Dec 1, 2021
External Links
Slate, Register, Google Patents

Bibliography

The patent EP3591073B1 was granted to Guardant Health on Dec 1, 2021 following the initial filing on Sep 4, 2013 under the application number EP19192885A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBSep 1, 2022ADMISSIBLE
MARGARET DIXONSep 1, 2022ADMISSIBLE

Patent Citations New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePatent NumberPatent Link
DESCRIPTIONUS2001053519
DESCRIPTIONUS2003152490
DESCRIPTIONUS2011160078
DESCRIPTIONUS6582908
DESCRIPTIONUS7537897
OPPOSITIONUS2011160078
OPPOSITIONUS2012165202
OPPOSITIONUS2013137588
OPPOSITIONUS8481292
OPPOSITIONWO2012042374
OPPOSITIONWO2012142213
OPPOSITIONWO2012148477
OPPOSITIONWO2013138510
OPPOSITIONWO2013142389
SEARCHUS8209130
SEARCHWO2008154317
SEARCHWO2014149134

Non-Patent Literature (NPL) Citations New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "HiSeq Analysis Software v0.9 User Guide", ILLUMINA, (201300), pages 1 - 46, URL: https://emea.supportillumina.com/content/dam/illumina-support/documents/documentation/software_documentation/has/has_userguide_15041353b.pdf, XP055960213-
OPPOSITION- Anonymous, "Illumina product guide 2009", Illumina, (20090000), pages 1 - 55, XP055960217-
OPPOSITION- Anonymous, "Interview with Professor Dennis Lo", Qiagen News, (20020101), no. 5, pages 2 - 3, XP055646625-
OPPOSITION- FORSHEW et al., "Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA", Science Translational Medicine, (20120530), vol. 4, no. 136, pages 1 - 33, XP055894926-
OPPOSITION- GATK TEAM, "PF Reads - Illumina Chastity Filter - GATK", Broad Institute, pages 1 - 2, URL: https://gatk.broadinstitute.org/hc/en-us/articles/360035890991-PF-reads-Illumina-chastity-filter, XP055960226-
OPPOSITION- KIVIOJA et al., "Counting absolute numbers of molecules using unique molecular identifiers", Nature Preceedings: hdl:10101/npre.2011.5903.1, (20110414), pages 1 - 32, XP055960230-
OPPOSITION- Thomas M. R., Tutschek B., Frost A., Rodeck C. H., Yazdani N., Craft I., Williamson R., "The time of appearance and disappearance of fetal DNA from the maternal circulation", Prenetal diagnosis, CHICHESTER, SUSSEX, GB, GB , (19950701), vol. 15, no. 7, doi:10.1002/pd.1970150709, ISSN 0197-3851, pages 641 - 646, XP093148417
OPPOSITION- Fleischhacker, M. Schmidt, B., "Circulating nucleic acids (CNAs) and cancer-A survey", Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, ELSEVIER SCIENCE BV, AMSTERDAM., NL, NL , (20061213), vol. 1775, no. 1, doi:10.1016/j.bbcan.2006.10.001, ISSN 0304-419X, pages 181 - 232, XP005802356
OPPOSITION- Teemu Kivioja, Anna Vähärautio, Kasper Karlsson, Martin Bonke, Martin Enge, Sten Linnarsson, Jussi Taipale, "Counting absolute numbers of molecules using unique molecular identifiers.", NATURE METHODS, Nature Publishing Group, GB, GB , (20120101), vol. 9, no. 1, doi:10.1038/nmeth.1778, ISSN 1548-7105, pages 72 - 74, XP002729237
OPPOSITION- Heidi Schwarzenbach, Dave S. B. Hoon, Klaus Pantel, "Cell-free nucleic acids as biomarkers in cancer patients", Nature Reviews Cancer, Nature Pub. Group, London, London , (20110601), vol. 11, no. 6, doi:10.1038/nrc3066, ISSN 1474-175X, pages 426 - 437, XP055247315
OPPOSITION- DIEHL et al., "Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients", Gastroenterology, (20080000), vol. 135, no. 2, doi:10.1053/j.gastro.2008.05.039, page 489, XP023901355
OPPOSITION- Diehl, F. ; Schmidt, K. ; Durkee, K.H. ; Moore, K.J. ; Goodman, S.N. ; Shuber, A.P. ; Kinzler, K.W. ; Vogelstein, B., "Analysis of Mutations in DNA Isolated From Plasma and Stool of Colorectal Cancer Patients", Gastroenterology, Elsevier Inc., US, US , (20080801), vol. 135, no. 2, doi:10.1053/j.gastro.2008.05.039, ISSN 0016-5085, pages 489 - 498.e7, XP023901355
OPPOSITION- FAN et al., "Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood", PNAS, (20081021), vol. 105, no. 42, doi:10.1073/pnas.0808319105, pages 16266 - 16271, XP055523982
OPPOSITION- H. C. Fan, Y. J. Blumenfeld, U. Chitkara, L. Hudgins, S. R. Quake, "Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20081021), vol. 105, no. 42, doi:10.1073/pnas.0808319105, ISSN 0027-8424, pages 16266 - 16271, XP055687023
OPPOSITION- R. W. K. Chiu, K. C. A. Chan, Y. Gao, V. Y. M. Lau, W. Zheng, T. Y. Leung, C. H. F. Foo, B. Xie, N. B. Y. Tsui, F. M. F. Lun, B. C. Y. Zee, T. K. Lau, C. R. Cantor, Y. M. D. Lo, "Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20081223), vol. 105, no. 51, doi:10.1073/pnas.0810641105, ISSN 0027-8424, pages 20458 - 20463, XP055284693
OPPOSITION- G. K. Fu, J. Hu, P.-H. Wang, S. P. A. Fodor, "Counting individual DNA molecules by the stochastic attachment of diverse labels", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20110531), vol. 108, no. 22, doi:10.1073/pnas.1017621108, ISSN 0027-8424, pages 9026 - 9031, XP055694849
OPPOSITION- KINDE et al., "Detection and quantification of rare mutations with massively parallel sequencing", PNAS, (20110607), vol. 108, no. 23, doi:10.1073/pnas.1105422108, pages 9530 - 9535, XP055815700
OPPOSITION- Kinde I., Wu J., Papadopoulos N., Kinzler K. W., Vogelstein B., "Detection and quantification of rare mutations with massively parallel sequencing", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20110607), vol. 108, no. 23, doi:10.1073/pnas.1105422108, ISSN 0027-8424, pages 9530 - 9535, XP055855692
OPPOSITION- M. W. Schmitt, S. R. Kennedy, J. J. Salk, E. J. Fox, J. B. Hiatt, L. A. Loeb, "Detection of ultra-rare mutations by next-generation sequencing", Proceedings of the National Academy of Sciences, National Academy of Sciences, (20120904), vol. 109, no. 36, doi:10.1073/pnas.1208715109, ISSN 00278424, pages 14508 - 14513, XP055161683
OPPOSITION- SCHMITT et al., "Detection of ultra-rare mutations by next-generation sequencing", PNAS, (20120904), vol. 109, no. 36, doi:10.1073/pnas.1208715109, pages 14508 - 14513, XP055928698
OPPOSITION- KRIMMEL et al., "Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues", PNAS, (20160524), vol. 113, no. 21, doi:10.1073/pnas.1601311113, pages 6002 - 6010, XP055894156
OPPOSITION- CASBON et al., "A method for counting PCR template molecules with application to next-generation sequencing", Nucleic Acids Research, (20110701), vol. 39, no. 12, doi:10.1093/nar/gkr217, page e81, XP055574095
OPPOSITION- T. Forshew, Murtaza M., Parkinson C., Gale D., Tsui D. W. Y., Kaper F., Dawson S.-J., Piskorz A. M., Jimenez-Linan M., Bentley D., Hadfield J., May A. P., Caldas C., Brenton J. D., Rosenfeld N., "Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA /Supplementary Materials/", Science Translational Medicine, doi:10.1126/scitranslmed.3003726, (20120530), pages 1 - 19, Science Translational Medicine, URL: https://stm.sciencemag.org/content/scitransmed/suppl/2012/05/25/4.136.136ra68.DC1/4-136ra68_SM.pdf, (20191126), XP055646640
OPPOSITION- LEARY et al., "Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing", Science Translational Medicine, (20121128), vol. 4, no. 162, doi:10.1126/scitranslmed.3004742, page 162, XP055565752
OPPOSITION- RIZZO J. et al., "Key principles and clinical applications of ''next generation'' DNA sequencing", Cancer Prevention Research, (20120700), vol. 5, no. 7, doi:10.1158/1940-6207.CAPR-11-0432, XP055486092
SEARCH- M. W. SCHMITT ET AL, "Detection of ultra-rare mutations by next-generation sequencing", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20120801), vol. 109, no. 36, doi:10.1073/pnas.1208715109, ISSN 0027-8424, pages 14508 - 14513, XP055161683 [A] 1-15 * page 14509, column l, paragraph l - column r, paragraph 2 * * figure 1 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents